hepatitis C

Positive Data Released On Idenix Pharmaceuticals IDX184 Hep C Drug
Seeking Alpha
Wed, 06/20/12 - 11:50 am
Indenix
hepatitis C
IDX184
Bristol CEO says Gilead holding out on hep C tie-up
Fierce Biotech
Fri, 06/1/12 - 12:30 pm
Bristol-Myers Squibb
Gilead
hepatitis C
Lamberto Andreotti
daclatasvir
GS-7977
Achillion jumps on hepatitis C study
Marketwatch
Mon, 05/21/12 - 04:49 pm
Achillion
hepatitis C
ACH-2684
U.S. Suggests All Baby Boomers Should Get Tested for Hepatitis C
WSJ
Sat, 05/19/12 - 12:08 pm
hepatitis C
Achillion's hepatitis C drug gets FDA fast track
Reuters
Tue, 05/15/12 - 12:11 pm
Achillion
hepatitis C
fast track
FDA
ACH-3102
Idenix Will Move Up On Promising New Data In 2013
City Bizlist
Sun, 05/13/12 - 01:12 pm
Idenix
IDX719
hepatitis C
Idenix Will Move Up On Promising New Data In 2013
Seeking Alpha
Sat, 05/12/12 - 11:17 am
Idenix
IDX719
hepatitis C
Maybe There Will Be Some Hep C Patients Left
Motley Fool
Sat, 04/28/12 - 12:21 pm
hepatitis C
Vertex Is Ready To Rise On INCIVEK Success
Seeking Alpha
Wed, 04/25/12 - 03:38 pm
Incivek
Vertex
hepatitis C
Abbott Laboratories
Amgen
Bristol-Myers Squibb
Gilead
Merck
Pfizer
Two Hepatitis C Treatments Win U.K. Health-Cost Agency Backing
Bloomberg
Wed, 04/25/12 - 10:17 am
hepatitis C
Victrelis
Merck
UK
JNJ
Incivo
Presidio Pharmaceuticals Announces a New Clinical Candidate, PPI-383, a Novel Pan-Genotypic Non-Nucleoside Polymerase Inhibitor for HCV
Pipeline Review
Sun, 04/22/12 - 12:25 pm
Presidio
PPI-383
hepatitis C
Gilead's Hepatitis C Drug Poised To Reach The Market As One Of The First 'All Oral' Combinations
Seeking Alpha
Sun, 04/22/12 - 12:04 pm
Gilead Sciences
GS-7977
hepatitis C
Gilead, Bristol Shine at EASL Conference
Motley Fool
Sun, 04/22/12 - 12:02 pm
Gilead Sciences
Bristol-Myers Squibb
GS-7977
daclatasvir
hepatitis C
Abbott Presents Positive Results From Phase 2 "Pilot" Study Of An Interferon-Free Combination Regimen For The Treatment Of Hepatitis C
Pharmaceutical Online
Sat, 04/21/12 - 01:03 pm
Abbott Laboratories
ABT-072
ABT-450
hepatitis C
Celebrate the Hep C Wins, for Now
Motley Fool
Sat, 04/21/12 - 12:26 pm
hepatitis C
Gilead Sciences
GS-7977
daclatasvir
Bristol-Myers Squibb
Abbott Laboratories
Vertex Pharmaceuticals
Incivek
5 Biotech Stocks That Could Soar On New Hepatitis C Drugs
Seeking Alpha
Sat, 04/21/12 - 12:17 pm
Vertex
Incivek
ABT-072
ABT-450
Abbott Laboratories
Achillion
ACH-1625
ACH-2684
ACH-2928
ACH-3102
TMC435
JNJ
GSK
hepatitis C
Achillion Announces 94 - 100% Complete EVR From Phase 2 Trial With ACH-1625 Based Regimen in Hepatitis C
Yahoo/Globe NewsWire
Sat, 04/21/12 - 12:05 pm
Achillion
ACH-1625
ACH-3102
ACH-2928
hepatitis C
Partner Up or Get Passed Up
Motley Fool
Sat, 04/21/12 - 11:51 am
GS-7977
Vertex Pharmaceuticals
hepatitis C
Roche
Bristol-Myers Squibb
Merck
Gilead Sciences
JNJ
Novartis halts hepatitis drug trial after death
Bloomberg Businessweek
Fri, 04/20/12 - 11:05 am
hepatitis C
Novartis
alisporivir
J&J Open to Expanding Hepatitis C Collaboration With Vertex
Bloomberg
Fri, 04/20/12 - 10:35 am
hepatitis C
JNJ
Vertex

Pages